abstract We conducted population anticoagulant pharmacodynamic analysis for patients administered the low-molecular weight heparin tinzaparin.
has subject area Adult Aged Double-Blind Method Female Fibrinolytic Agents Half-Life Heparin, Low-Molecular-Weight Humans Male Metabolic Clearance Rate Middle Aged Models, Biological Population Surveillance Randomized Controlled Trials as Topic Venous Thrombosis